The effect of bone morphogenic protein-2 (BMP-2)-immobilizing heparinized-chitosan scaffolds for enhanced osteoblast activity

  • Young-Pil Yun
  • Sung Eun Kim
  • Eun Young Kang
  • Hak-Jun Kim
  • Kyeongsoon Park
  • Hae-Ryong Song
Original Article


The aim of orthopedic and dental tissue engineering is to generate synthetic bone-graft tissue substitutes. It is generally comprised through the combination of viable cells, a scaffolding material, and sometimes the inclusion of bone morphogenic proteins. The object of this study is to develop novel bone-grafting scaffolds that enhance osteoblast activity. We were fabricated the chitosan scaffolds with channel-shaped and spherically shaped pore morphologies. Also, Bone morphogenic protein-2 (BMP-2) was sequentially immobilized to the heparinized-chitosan (Hep-chitosan) scaffolds. Osteoblast activities of all chitosan scaffolds were investigated by a cell proliferation assay, alkaline phosphatase (ALP) activity, calcium deposition, and the expression of osteogenic markers. The results showed that BMP-2-immobilizing heparinized-chitosan (BMP-2/Hep-chitosan) scaffolds significantly enhanced ALP activity and calcium deposition of the osteoblast cells when compared with chitosan scaffolds only. Also, mRNA expressions of osteocalcin and osteopontin of osteoblast cells cultured on BMP-2 (100 ng)/Hep-chitosan scaffolds were increased versus chitosan scaffolds only. Taken together, BMP-2 (100 ng)/Hep-chitosan scaffolds could achieve the functions of excellent osteoblast promotion. Therefore, osteoinductive protein-functionalizing scaffold substrates such as BMP-2/Hepchitosan scaffolds are a promising material for the enhanced osteoblast activity in orthopedic and dental fields.

Key words

chitosan scaffolds bone morphogenic protein-2(BMP-2) heparin enhancement of osteoblast functions 



Extracellular matrix


Dulbecco’s modified eagles’ medium


Fetal bovine serum


Phosphate-buffered saline


1-ethyl-3dimethylaminopropyl carbodiimide


[2-(N-Morpholino) ethanesulfonic Acid]


Alkaline phosphatase


Real-time polymerase chain reaction


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A Khademhosseini, R Langer, J Borenstein, et al., Microscale technologies for tissue engineering and biology, Proc Natl Acad Sci USA, 103, 2480 (2006).PubMedCrossRefGoogle Scholar
  2. 2.
    QP Pham, U Sharma, AG Mikos, Electrospun poly(epsiloncaprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration, Biomacromolecules, 7, 2796 (2006).PubMedCrossRefGoogle Scholar
  3. 3.
    E Khor, LY Lim, Implantable applications of chitin and chitosan, Biomaterials, 24, 2339 (2003).PubMedCrossRefGoogle Scholar
  4. 4.
    CKS Pillai, W Paul, CP Sharma, Chitin and chitosan polymers: chemistry, solubility and fiber formation, Progress Polym Sci, 34, 641 (2009).CrossRefGoogle Scholar
  5. 5.
    AC Larkin, RM Davis, P Rajagopalan, Biocompatible, detachable, and free-standing polyelectrolyte multilayer films, Biomacromolecules, 11, 2788 (2010).PubMedCrossRefGoogle Scholar
  6. 6.
    BG Amsden, A Sukarto, DK Knight, et al., Methacrylated glycol chitosan as a photopolymerizable biomaterial, Biomacromolecules, 8, 3758 (2007).PubMedCrossRefGoogle Scholar
  7. 7.
    VK Mourya, NN Inamdar, Chitosan-modifications and applications: opportunities galore, React Funct Polym, 68, 1013 (2008).CrossRefGoogle Scholar
  8. 8.
    D Depan, AK Pratheep, RP Singh, Cell proliferation and controlled drug release studies of nanohybrids based on chitosanglactic acid and montmorillonite, Acta Biomater, 5, 93 (2009).PubMedCrossRefGoogle Scholar
  9. 9.
    YY Liang, LM Zhang, Bioconjugation of papain on superparamagnetic nanoparticles decorated with carboxymethylated chitosan, Biomacromolecules, 8, 1480 (2007).PubMedCrossRefGoogle Scholar
  10. 10.
    N Bordenave, S Grelier, V Coma, Hydrophobization and antimicrobial activity of chitosan and paper-based packaging material, Biomacromolecules, 11, 88 (2010).PubMedCrossRefGoogle Scholar
  11. 11.
    Y Sheng, C Liu, Y Yuan, et al., Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan, Biomaterials, 30, 2340 (2009).PubMedCrossRefGoogle Scholar
  12. 12.
    GK Tan, DL Dinnes, LN Butler, et al., Interactions between meniscal cells and a self assembled biomimetic surface composed of hyaluronic acid, chitosan and meniscal extracellular matrix molecules, Biomaterials, 31, 6104 (2010).Google Scholar
  13. 13.
    R Sasisekharan, S Ernst, G Venkataraman, On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans, Angiogenesis, 1, 45 (1997).PubMedCrossRefGoogle Scholar
  14. 14.
    MJ Wissink, R Beernink, NM Scharenborg, et al., Endothelial cell seeding of (heparinized) collagen matrices: effects of bFGF pre-loading on proliferation (after low density seeding) and procoagulant factors, J Control Release, 67, 141 (2000).PubMedCrossRefGoogle Scholar
  15. 15.
    MJ Wissink, R Beernink, AA Poot, et al., Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices, J Control Release, 64, 103 (2000).PubMedCrossRefGoogle Scholar
  16. 16.
    GC Steffens, C Yao, P Prevel, et al., Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor, Tissue Eng, 10, 1502 (2004).PubMedGoogle Scholar
  17. 17.
    ST Nillesen, PJ Geutjes, R Wismans, et al., Increased angiogenesis and blood vessel maturation in acellular collageneheparin scaffolds containing both FGF2 and VEGF, Biomaterials, 28, 1123 (2007).PubMedCrossRefGoogle Scholar
  18. 18.
    A Perets, Y Baruch, F Weisbuch, et al., Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres, J Biomed Mater Res A, 65, 489 (2003).PubMedCrossRefGoogle Scholar
  19. 19.
    T Ishibe, T Goto, T Kodama, et al., Bone formation on apatitecoated titanium with incorporated BMP-2/heparin in vivo, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 108, 867 (2009).PubMedCrossRefGoogle Scholar
  20. 20.
    SE Kim, SH Song, YP Yun, et al., The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function, Biomaterials, 32, 366 (2011).PubMedCrossRefGoogle Scholar
  21. 21.
    HJ Moon, YP Yun, CW Han, et al., Effect of heparin and alendronate coating on titanium surfaces on inhibition of osteoclast and enhancement of osteoblast function, Biochem Biophys Res Commun, 413, 194 (2011).PubMedCrossRefGoogle Scholar
  22. 22.
    DW Lee, YP Yun, K Park, et al., Gentamicin and bone morphogenic protein-2 (BMP-2)-delivering heparinizedtitanium implant with enhanced antibacterial activity and osteointegration, Bone, 50, 974 (2012).PubMedCrossRefGoogle Scholar
  23. 23.
    ISO document 10993. Biological compatibility of medical devices* Part 5. Tests for cytotoxicity: in vitro methods, December 1992.Google Scholar
  24. 24.
    Z Shi, KG Neoh, ET Kang, et al., Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration, Biomacromolecules, 10, 1603 (2009).PubMedCrossRefGoogle Scholar
  25. 25.
    RH Christenson, Biochemical markers of bone metabolism: an overview, Clin Biochem, 30, 573 (1997).PubMedCrossRefGoogle Scholar
  26. 26.
    NK Lee, H Sowa, E Hinoi, et al., Endocrine regulation of energy metabolism by the skeleton, Cell, 130, 456 (2007).PubMedCrossRefGoogle Scholar
  27. 27.
    K Whang, KE Healy, DR Elenz, et al., Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture, Tissue Eng, 5, 35 (1999).PubMedCrossRefGoogle Scholar
  28. 28.
    MC Wake, Jr CW Patrick, AG Mikos, Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates, Cell Transplant, 3, 339 (1994).PubMedGoogle Scholar
  29. 29.
    N Sykaras, LA Opperman, Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician?, J Oral Sci, 45, 57 (2003).PubMedCrossRefGoogle Scholar
  30. 30.
    BS Vladimirov, SA Dimitrov, Growth factors—importance and possibilities for enhancement of the healing process in bone fractures, Folia Med (Plovdiv), 46, 11 (2004).Google Scholar
  31. 31.
    JM Wozney, V Rosen, AJ Celeste, et al., Novel regulators of bone formation: molecular clones and activities, Science, 242, 1528 (1988).PubMedCrossRefGoogle Scholar
  32. 32.
    MR Urist, Bone: formation by autoinduction, Science, 150, 893 (1965).PubMedCrossRefGoogle Scholar
  33. 33.
    S Hirota, K Takaoka, J Hashimoto, et al., Expression of mRNA of murine bone-related proteins in ectopic bone induced by murine bone morphogenetic protein-4, Cell Tissue Res, 277, 27 (1994).PubMedCrossRefGoogle Scholar
  34. 34.
    J Becerra, JA Andrades, JA Santamaria, et al., Bone regeneration, cell therapy and tissue engineering, Med Clin (Barc), 116, 23 (2001).CrossRefGoogle Scholar
  35. 35.
    BE Bax, JM Wozney, DE Ashhurst, Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia, Calcif Tissue Int, 65, 83 (1999).PubMedCrossRefGoogle Scholar
  36. 36.
    GN King, N King, AT Cruchley, et al., Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects, J Dent Res, 76, 1460 (1997).PubMedCrossRefGoogle Scholar
  37. 37.
    RS Sellers, D Peluso, EA Morris, The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage, J Bone Jt Surg Am, 79, 1452 (1997).Google Scholar
  38. 38.
    G Zellin, A Linde, Importance of delivery systems for growthstimulatory factors in combination with osteopromotive membranes. an experimental study using rhBMP-2 in rat mandibular defects, J Biomed Mater Res, 35, 181 (1997).PubMedCrossRefGoogle Scholar
  39. 39.
    J Kim, Y Park, G Tae, et al., Characterization of low-molecularweight hyaluronic acid-based hydrogel and differential stem cell responses in the hydrogel microenvironments, J Biomed Mater Res A, 88, 967 (2009).PubMedGoogle Scholar
  40. 40.
    J Kim, IS Kim, TH Cho, et al., Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells, Biomaterials, 28, 1830 (2007).PubMedCrossRefGoogle Scholar
  41. 41.
    H Lin, Y Zhao, W Sun, et al., The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2, Biomaterials, 29, 1189 (2008).PubMedCrossRefGoogle Scholar
  42. 42.
    S Yang, KF Leong, Z Du, et al., The design of scaffolds for use in tissue engineering. Part I. traditional factors, Tissue Eng, 7, 679 (2001).PubMedCrossRefGoogle Scholar
  43. 43.
    K Turksen, U Bhargava, HK Moe, et al., Isolation of monoclonal antibodies recognizing rat bone-associated molecules in vitro and in vivo, J Histochem Cytochem, 40, 1339 (1992).PubMedCrossRefGoogle Scholar
  44. 44.
    JJ van den Beucken, XF Walboomers, OC Boerman, et al., Functionalization of multilayered DNA-coatings with bone morphogenetic protein 2, J Control Release, 113, 63 (2006).PubMedCrossRefGoogle Scholar
  45. 45.
    YJ Park, KH Kim, JY Lee, et al., Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration, Biotechnol Appl Biochem, 43, 17 (2006).PubMedCrossRefGoogle Scholar
  46. 46.
    ST Choi, JH Kim, EJ Kang, et al., Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis, Rheumatology, 47, 1775 (2008).PubMedCrossRefGoogle Scholar
  47. 47.
    F Deschaseaux, L Sensebe, D Heymann, Mechanisms of bone repair and regeneration, Trends Mol Med, 15, 417 (2009).PubMedCrossRefGoogle Scholar

Copyright information

© The Korean Tissue Engineering and Regenerative Medicine Society and Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Young-Pil Yun
    • 1
  • Sung Eun Kim
    • 1
  • Eun Young Kang
    • 1
  • Hak-Jun Kim
    • 1
  • Kyeongsoon Park
    • 2
  • Hae-Ryong Song
    • 1
  1. 1.Department of Orthopedic Surgery and Rare Diseases InstituteKorea University Medical Center, Guro HospitalSeoulKorea
  2. 2.Division of Biological Imaging, Chuncheon CenterKorea Basic Science InstituteChuncheon, Gangwon-doKorea

Personalised recommendations